Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bausch + Lomb Corporation Common Shares
(NY:
BLCO
)
16.50
+0.30 (+1.85%)
Streaming Delayed Price
Updated: 1:19 PM EDT, Jul 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bausch + Lomb Corporation Common Shares
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
6 Analysts Have This to Say About Bausch & Lomb
↗
October 03, 2023
Via
Benzinga
Bausch Health's Bausch + Lomb Announces Completion of the Acquisition of XIIDRA(R)
September 29, 2023
Via
ACCESSWIRE
Bausch + Lomb Completes Acquisition of XIIDRA®
September 29, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Launches LUMIFY EYE ILLUMINATIONS™ in the United States
September 26, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Earnings Preview: Bausch & Lomb
↗
August 01, 2023
Via
Benzinga
Analyst Ratings for Bausch & Lomb
↗
July 24, 2023
Via
Benzinga
Analyst Ratings for Bausch & Lomb
↗
July 03, 2023
Via
Benzinga
Bausch + Lomb’s ONE by ONE and Biotrue® Eye Care Recycling Programs Recognized As Sustainability Service of the Year Award Winners
September 20, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces Pricing of Senior Secured Notes Offering
September 14, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Launches MIEBO™ (Perfluorohexyloctane Ophthalmic Solution) in the United States
September 12, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch Health's Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA(R)
September 11, 2023
Via
ACCESSWIRE
Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA®
September 11, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Global Dry Eye Syndrome Treatment Market Expected to Reach $11.26 Billion By 2030
September 08, 2023
EQNX::TICKER_START (NASDAQ:OKYO),(NYSE:ALC),(NYSE:BLCO),(NYSE:JNJ),(OTCQX:RHHBY) EQNX::TICKER_END
Via
FinancialNewsMedia
Bausch + Lomb Announces Disclosure of Historical and Pro Forma Financial Information With Respect to Acquisition of XIIDRA®
September 06, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual Meeting
September 06, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Will Participate at the 2023 Wells Fargo Healthcare Conference
August 29, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of XIIDRA®
August 24, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces Second-Quarter 2023 Results and Raises Full-Year 2023 Revenue Outlook
August 02, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Solidifies Leadership Team
August 01, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Will Release Second-Quarter 2023 Financial Results on August 2
July 11, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Expands OTC Eye Care Portfolio, Acquires JNJ's Blink
↗
July 06, 2023
Bausch + Lomb Corporation (NYSE: BLCO) has acquired Johnson & Johnson's (NYSE: JNJ) eye and contact lens drops brand Blink for $106.5 million to bolster its position in over-the-counter (OTC)...
Via
Benzinga
Bausch + Lomb Expands OTC Product Line with Acquisition of Blink® Eye Drops
July 06, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Carnival, SMART Global, Friedman Industries And Other Big Stocks Moving Higher On Friday
↗
June 30, 2023
U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Amazon Hires Dozens of Former FTC Officials, Volkswagen Discusses With Tesla to Adopt North American Charging Standard, FDA Approves First Hemophilia A BioMarin Gene Therapy: Today's Top Stories
↗
June 30, 2023
New York Post
Via
Benzinga
Bausch + Lomb Poised To Boost Presence In Growing Market With Potential $1.75B Drug Acquisition Deal From Novartis
↗
June 30, 2023
Bausch + Lomb Corporation (NYSE: BLCO) has agreed to acquire 'front of eye' ophthalmology assets for $1.75 billion in upfront cash, plus additional milestone payments from Novartis AG (NYSE:
Via
Benzinga
Bausch Health’s Bausch + Lomb to Acquire Novartis’ XIIDRA(R)
June 30, 2023
Via
ACCESSWIRE
Bausch + Lomb Will Acquire XIIDRA®
June 30, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Launches PreserVision® AREDS 2 Formula Soft Gels Plus CoQ10 in the United States
June 12, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces New Scientific Data and Analyses Featuring Consumer, Vision Care and Pharmaceutical Products Will Be Presented During American Optometric Association's Optometry's Meeting
June 08, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Launches Biotrue® Hydration Boost Contact Lens Rehydrating Drops in the United States
June 06, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
